IL141033A0 - Estradiol containing patch for transdermal administration of hormones - Google Patents

Estradiol containing patch for transdermal administration of hormones

Info

Publication number
IL141033A0
IL141033A0 IL14103399A IL14103399A IL141033A0 IL 141033 A0 IL141033 A0 IL 141033A0 IL 14103399 A IL14103399 A IL 14103399A IL 14103399 A IL14103399 A IL 14103399A IL 141033 A0 IL141033 A0 IL 141033A0
Authority
IL
Israel
Prior art keywords
hormones
transdermal administration
containing patch
estradiol containing
estradiol
Prior art date
Application number
IL14103399A
Other languages
English (en)
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7875613&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL141033(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of IL141033A0 publication Critical patent/IL141033A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/65—Characterized by the composition of the particulate/core
    • A61K2800/651—The particulate/core comprising inorganic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
IL14103399A 1998-07-29 1999-07-16 Estradiol containing patch for transdermal administration of hormones IL141033A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19834007A DE19834007C1 (de) 1998-07-29 1998-07-29 Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen und seine Verwendung
PCT/EP1999/005085 WO2000006131A1 (de) 1998-07-29 1999-07-16 Estradiolhaltiges pflaster zur transdermalen applikation von hormonen

Publications (1)

Publication Number Publication Date
IL141033A0 true IL141033A0 (en) 2002-02-10

Family

ID=7875613

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14103399A IL141033A0 (en) 1998-07-29 1999-07-16 Estradiol containing patch for transdermal administration of hormones
IL141033A IL141033A (en) 1998-07-29 2001-01-23 Estradiol-containing patch for transdermal administration of hormones

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL141033A IL141033A (en) 1998-07-29 2001-01-23 Estradiol-containing patch for transdermal administration of hormones

Country Status (18)

Country Link
US (1) US6531149B1 (es)
EP (1) EP1100477B1 (es)
JP (1) JP2002521427A (es)
KR (1) KR100559089B1 (es)
CN (1) CN1172661C (es)
AR (1) AR021459A1 (es)
AT (1) ATE264097T1 (es)
AU (1) AU758107B2 (es)
BR (1) BR9912687A (es)
CA (1) CA2338859C (es)
DE (2) DE19834007C1 (es)
ES (1) ES2220093T3 (es)
IL (2) IL141033A0 (es)
PL (1) PL194102B1 (es)
TR (1) TR200100289T2 (es)
TW (1) TW542726B (es)
WO (1) WO2000006131A1 (es)
ZA (1) ZA200100719B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10304988A1 (de) * 2003-02-07 2004-09-09 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System mit verbessertem Hautklebeverhalten
WO2005000198A2 (en) 2003-05-07 2005-01-06 Cedars-Sinai Medical Center An intracellular estradiol binding protein, a polynucleotide encoding the same and cell lines overexpressing the same
US7251128B2 (en) * 2004-09-30 2007-07-31 Intel Corporation Adjustable portable computer
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
ES2885523T3 (es) 2011-11-23 2021-12-14 Therapeuticsmd Inc Formulaciones y terapias de reposición hormonal de combinación naturales
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE251567C (es)
NL6902314A (es) 1969-02-13 1970-08-17
US3637224A (en) 1969-02-27 1972-01-25 Fedders Corp Annular sealing ring
US4379454A (en) 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
CA1248450A (en) * 1984-04-05 1989-01-10 Kazuo Kigasawa Soft patch
US4624665A (en) 1984-10-01 1986-11-25 Biotek, Inc. Method of transdermal drug delivery
US4720489A (en) * 1984-10-15 1988-01-19 Douglas Shander Hair growth modification with ornithine decarboxylase inhibitors
EP0186019B1 (de) * 1984-12-22 1993-10-06 Schwarz Pharma Ag Wirkstoffpflaster
US4883669A (en) 1985-02-25 1989-11-28 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
DD251567A1 (de) * 1986-07-30 1987-11-18 Jenapharm Veb Verfahren zur herstellung gefaerbter, selbstklebender loesungsmittelhaltiger polymermischungen
CN1021196C (zh) 1986-12-29 1993-06-16 新泽西州州立大学(鲁杰斯) 透皮雌激素/孕激素药剂单元、系统及方法
CH674618A5 (es) 1987-04-02 1990-06-29 Ciba Geigy Ag
DE3743946A1 (de) 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von nitroglycerin an die haut, verfahren zu ihrer herstellung sowie ihre verwendung
US4906475A (en) 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
JPH02180835A (ja) * 1988-12-29 1990-07-13 Lion Corp 外用製剤
EP0409383B1 (en) * 1989-07-21 1994-04-06 Izhak Blank Estradiol compositions and methods for topical applications
WO1991003219A1 (en) * 1989-09-08 1991-03-21 Cygnus Research Corporation Solid matrix system for transdermal drug delivery
JP3273430B2 (ja) * 1989-12-28 2002-04-08 日東電工株式会社 エストロゲン含有ゲル製剤
DE4115849A1 (de) * 1991-05-15 1992-11-19 Lohmann Therapie Syst Lts Penetrationsfoerdernde substanz
JPH04342532A (ja) * 1991-05-21 1992-11-30 Sekisui Chem Co Ltd 経皮吸収貼付剤
JP3086288B2 (ja) * 1991-07-23 2000-09-11 扶桑薬品工業株式会社 経皮吸収製剤
JPH05148135A (ja) * 1991-11-29 1993-06-15 L T T Kenkyusho:Kk 貼付剤用物理的吸収促進剤及びそれを含む貼付剤
DE4230588C1 (de) * 1992-09-12 1993-10-07 Lohmann Therapie Syst Lts Dexpanthenol-haltiges Pflaster zur transdermalen Applikation von Steroidhormonen und Verfahren zu seiner Herstellung
JP2569396B2 (ja) * 1992-12-04 1997-01-08 株式会社太平洋 経皮投与型薬物用貼付剤
JP3197102B2 (ja) * 1993-03-29 2001-08-13 積水化学工業株式会社 経皮吸収製剤及びその製造方法
JP3305101B2 (ja) * 1994-03-29 2002-07-22 積水化学工業株式会社 経皮吸収製剤
DE4416927C1 (de) * 1994-05-13 1995-08-31 Lohmann Therapie Syst Lts Vorrichtung zur Abgabe von Wirkstoffen aus Haftschmelzklebern, Verfahren zu ihrer Herstellung und ihre Verwendung
JPH0827003A (ja) * 1994-07-22 1996-01-30 Sekisui Chem Co Ltd 経皮吸収製剤
AU692944B2 (en) * 1994-11-18 1998-06-18 Hisamitsu Pharmaceutical Co., Inc. Percutaneously absorbable patch
EP0746311B1 (en) 1994-12-24 2001-07-11 Pacific Corporation Medicinal patches for percutaneous administration
HU228434B1 (en) * 1995-06-07 2013-03-28 Ortho Mcneil Pharm Inc Transdermal medicament for administering 17-deacetyl norgestimate alone or in combination with an estrogen
US5783208A (en) * 1996-07-19 1998-07-21 Theratech, Inc. Transdermal drug delivery matrix for coadministering estradiol and another steroid
US5948433A (en) * 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch

Also Published As

Publication number Publication date
TW542726B (en) 2003-07-21
DE59909189D1 (de) 2004-05-19
KR20010079571A (ko) 2001-08-22
AU758107B2 (en) 2003-03-13
KR100559089B1 (ko) 2006-03-13
ATE264097T1 (de) 2004-04-15
IL141033A (en) 2009-06-15
TR200100289T2 (tr) 2001-07-23
EP1100477B1 (de) 2004-04-14
JP2002521427A (ja) 2002-07-16
PL345695A1 (en) 2002-01-02
ZA200100719B (en) 2002-06-14
CN1310614A (zh) 2001-08-29
US6531149B1 (en) 2003-03-11
DE19834007C1 (de) 2000-02-24
AR021459A1 (es) 2002-07-24
CA2338859A1 (en) 2000-02-10
BR9912687A (pt) 2001-06-05
EP1100477A1 (de) 2001-05-23
AU5160799A (en) 2000-02-21
PL194102B1 (pl) 2007-04-30
CN1172661C (zh) 2004-10-27
WO2000006131A1 (de) 2000-02-10
ES2220093T3 (es) 2004-12-01
CA2338859C (en) 2007-09-18

Similar Documents

Publication Publication Date Title
IL141033A0 (en) Estradiol containing patch for transdermal administration of hormones
AU3654697A (en) Transdermal application of naturally occurring steriod hormones
GB2328375B (en) Transdermal patch
HUP0200416A3 (en) Pharmaceutical composition useful for low dose estrogen interrupted hormone replacement therapy
HUP0000615A3 (en) Process for producing transdermal pharmaceutical compositions containing penetration increasing substance
HK1043788A1 (zh) 四環黃體酮受體調節劑化合物及方法
IL138509A0 (en) Topical transdermal anesthetic formulation
ZA974981B (en) A novel composition for transdermal administration of an estrogen, a progestin or a mixture thereof.
HUP0202814A3 (en) Androgen receptor modulator compounds and methods for their preparation and pharmaceutical compositions containing them and their use
AU7601998A (en) Composition and methods for transdermal delivery of acid labile drugs
HUP0001748A3 (en) Transdermal device for the delivery of testosterone
GB2362825B (en) Transdermal patch for nonsteroidal antiinflammatory drug(s)
HUP0204291A3 (en) Use of composition containing estrogen and drospirenone for hormone replacement therapy
AU6017698A (en) Fillable patch for dermal or transdermal delivery
AU7578598A (en) Controlled release dosage forms containing water soluble drugs
HUP0102498A3 (en) Transdermal therapeutic system containing steroid hormones and crystallization inhibitors
AU2001277671A1 (en) Apparatus and applicator patch for transdermal substance delivery
HUP0000445A3 (en) Flat transdermal medicated self-adhesive patch
AU3869399A (en) Transdermal administration of fenoldopam
AU9621598A (en) Luteinising hormone antagonists useful for treatment of estrogen deficiencies, or as a contraceptive
GB9918735D0 (en) Transdermal patches
CA2183960A1 (en) Medical stamps for percutaneous administration
IL141032A0 (en) Estradiol-containing patch for transdermal administration of hormones
AU1330901A (en) Compounds and methods for modulating non-transcriptional effects of steroid hormones
AU2882699A (en) Stabilizing composition for pharmaceutical dosage forms